MedPath

Prednisolone

Generic Name
Prednisolone
Brand Names
Millipred Dp 6 Day
Drug Type
Small Molecule
Chemical Formula
C21H28O5
CAS Number
50-24-8
Unique Ingredient Identifier
9PHQ9Y1OLM
Background

Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.

Prednisolone was granted FDA approval on 21 June 1955.

Indication

Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Allergic Bronchopulmonary Aspergillosis, Allergic Conjunctivitis (AC), Allergic Contact Dermatitis, Allergic Skin Reaction, Allergic corneal marginal ulcers, Alveolitis, Extrinsic Allergic, Ankylosing Spondylitis (AS), Aspiration Pneumonia, Aspiration Pneumonitis, Atopic Dermatitis, Bell's Palsy, Berylliosis, Bullous dermatitis herpetiformis, Burns, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Corneal injuries, Corneal ulceration, Crohn's Disease (CD), Cyclitis, Dermatomyositis (DM), Dermatosis of the Ear Canal, Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Erythroblastopenia, Exacerbation of COPD, Exacerbation of asthma, Eye inflammation caused by Cataract Surgery, Eye inflammation caused by Infection, Fissure;Anal, Herpes Zoster Keratitis, Hot Water Burns (Scalds), Hypercalcemia of Malignancy, Idiopathic Pulmonary Fibrosis (IPF), Immune Thrombocytopenia (ITP), Inflamed External Hemorrhoid, Inflamed Hemorrhoids, Internal, Inflammatory Reaction caused by susceptible Bacterial Infections, Iridocyclitis, Iritis, Itching caused by susceptible Bacterial Infections, Keratitis, Loeffler's syndrome, Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Multiple sclerosis exacerbation, Mycosis Fungoides (MF), Ocular Inflammation, Ophthalmia, Sympathetic, Optic Neuritis, Otic Eczema, Pemphigus, Perennial Allergic Rhinitis (PAR), Pericarditis, Pneumocystis Jirovecii Pneumonia, Polymyalgia Rheumatica (PMR), Posterior Uveitis, Posttraumatic Osteoarthritis, Proctitis, Proteinuria, Pruritus, Pruritus Ani, Psoriatic Arthritis, Pulmonary Tuberculosis (TB), Pure Red Cell Aplasia, Rash, Relapsing Polychondritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Seasonal Allergic Rhinitis, Secondary Adrenal Insufficiency, Secondary thrombocytopenia, Serum Sickness, Severe Asthma, Sjogren's Syndrome (SS), Stevens-Johnson Syndrome, Superficial punctate keratitis, Synovitis, Systemic Lupus Erythematosus, Transplanted Organ Rejection, Trichinosis, Tuberculosis (TB), Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Vasculitis, Acquired immune hemolytic anemia, Acute Bursitis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Anal eczema, Bacterial skin infections, Exfoliative erythroderma, Idiopathic Bronchiolitis obliterans with organizing pneumonia, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Primary adrenocoritical insufficiency, Severe Psoriasis, Severe Seborrhoeic dermatitis, Severe alcoholic liver disease, Steroid-responsive inflammation of the eye, Subacute Bursitis, Susceptible Bacterial Infections, Symptomatic Sarcoidosis, Varicella-zoster virus acute retinal necrosis

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Phase 1
Recruiting
Conditions
Bell Palsy
Interventions
First Posted Date
2023-04-20
Last Posted Date
2024-04-03
Lead Sponsor
October 6 University
Target Recruit Count
90
Registration Number
NCT05821075
Locations
🇪🇬

October 6 university hospital, Giza, Egypt

Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD

Not Applicable
Recruiting
Conditions
IgG4-related Disease With Eosinophilia
Interventions
First Posted Date
2023-03-23
Last Posted Date
2023-03-27
Lead Sponsor
Wen Zhang
Target Recruit Count
74
Registration Number
NCT05781516
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Bejing, China

Efficacy and Safety of AC102 Compared to Steroids in Adults with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

Phase 2
Recruiting
Conditions
Hearing Loss, Sensorineural
Interventions
Drug: AC102 gel
Other: Placebo Tablets
Other: Placebo gel
First Posted Date
2023-03-20
Last Posted Date
2025-02-03
Lead Sponsor
AudioCure Pharma GmbH
Target Recruit Count
210
Registration Number
NCT05776459
Locations
🇩🇪

Klinik für Hals-, Nasen-, Ohrenheilkunde - Charité Campus Benjamin Franklin - HNO Hochschulambulanz, Berlin, Germany

🇩🇪

University Hospital Dresden 'Carl Gustav Carus' - HNO, Dresden, Germany

🇩🇪

Evangelisches Krankenhaus - Universitätsklinik für HNO, Oldenburg, Germany

and more 37 locations

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Phase 2
Recruiting
Conditions
Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia
Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia
Recurrent Mixed Phenotype Acute Leukemia
Recurrent Acute Leukemia of Ambiguous Lineage
Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged
Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged
Recurrent Acute Lymphoblastic Leukemia
Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage
Refractory Acute Leukemia of Ambiguous Lineage
Refractory Acute Lymphoblastic Leukemia
Interventions
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Echocardiography
Procedure: Lumbar Puncture
Procedure: Multigated Acquisition Scan
First Posted Date
2023-03-09
Last Posted Date
2025-03-19
Lead Sponsor
Children's Oncology Group
Target Recruit Count
78
Registration Number
NCT05761171
Locations
🇺🇸

Children's Hospital of Alabama, Birmingham, Alabama, United States

🇺🇸

Arkansas Children's Hospital, Little Rock, Arkansas, United States

🇺🇸

Kaiser Permanente Downey Medical Center, Downey, California, United States

and more 66 locations

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

Phase 3
Recruiting
Conditions
Takayasu Arteritis
Interventions
Other: Placebo of prednisolone
Other: Placebo of tofacitinib 5mg
First Posted Date
2023-03-01
Last Posted Date
2023-03-01
Lead Sponsor
Chinese SLE Treatment And Research Group
Target Recruit Count
50
Registration Number
NCT05749666
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages

Phase 4
Recruiting
Conditions
Habitual Abortion
Miscarriage
Recurrent Pregnancy Loss
Fertility Disorders
Recurrent Miscarriage
Interventions
Drug: Placebo
First Posted Date
2023-02-13
Last Posted Date
2024-05-24
Lead Sponsor
Leiden University Medical Center
Target Recruit Count
490
Registration Number
NCT05725512
Locations
🇳🇱

Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population

Phase 3
Recruiting
Conditions
Cataracts Infantile
Interventions
First Posted Date
2023-02-13
Last Posted Date
2023-02-13
Lead Sponsor
Salvat
Target Recruit Count
60
Registration Number
NCT05724446
Locations
🇪🇸

Hospìtal Sant Joan de Deu, Barcelone, Spain

Prednisolone Versus Colchicine for Acute Gout in Primary Care

Phase 4
Recruiting
Conditions
Acute Gout
Interventions
First Posted Date
2023-01-26
Last Posted Date
2025-04-22
Lead Sponsor
University Medicine Greifswald
Target Recruit Count
314
Registration Number
NCT05698680
Locations
🇩🇪

Arztpraxis Burgtorstr. 2, Ittlingen, Baden-Württemberg, Germany

🇩🇪

Hausarztpraxis Neckarsteinacher Str. 22, Neckargemünd, Baden-Württemberg, Germany

🇩🇪

Hausarztpraxis Kleinfeldlein 3, Bad Bocklet, Bayern, Germany

and more 62 locations

Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS

Phase 2
Not yet recruiting
Conditions
Sjogren Syndrome With Other Organ Involvement
Interventions
First Posted Date
2023-01-23
Last Posted Date
2023-01-23
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
110
Registration Number
NCT05694130

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Phase 3
Recruiting
Conditions
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Interventions
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Other: Fludeoxyglucose F-18
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
Radiation: Involved-site Radiation Therapy
First Posted Date
2023-01-09
Last Posted Date
2025-05-18
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
1875
Registration Number
NCT05675410
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

🇺🇸

USA Health Strada Patient Care Center, Mobile, Alabama, United States

🇺🇸

Providence Alaska Medical Center, Anchorage, Alaska, United States

and more 344 locations
© Copyright 2025. All Rights Reserved by MedPath